Abstract: The present invention relates to an end cap for a rodless cylinder (101) provided with a sealing strip (110). The end cap comprises an end cap body (102, 104) and a channel (105). The end cap body (102, 104) is configured to sealingly fit to a cylinder body (101). The channel (105) is formed in the end cap body (102, 104) and adapted to receive the sealing strip (110). The end cap includes a clamping lever (15) pivotally affixed to the end cap body (102, 104), with the clamping lever (15) including a clamping surface (90) that clamps the sealing strip (110) within the channel (105) when the clamping lever (15) is moved to a substantially closed position.

Abstract: A piston portion (102) for a piston assembly (100) is provided according to an embodiment of the invention. The piston portion (102) includes a substantially cylindrical head portion (103) including a mating face (105). The piston portion (102) further includes a substantially annular insert chamber (126) formed in the mating face (105) and adapted for receiving a portion of a substantially annular insert (120).

Abstract: A locking piston assembly (100) is provided according to the invention. The locking piston assembly (100) includes a piston chamber (107), a piston rod (106) configured to be substantially extended from and substantially retracted into the piston chamber (107), and a piston head (108) coupled to the piston rod (106) and configured to move reciprocally in the piston chamber (107). The locking piston assembly (100) further includes at least one lock (120) configured to mechanically lock the piston head (108) and the piston rod (106) in at least a substantially fully extended position. The lock (120) is configured to unlock the piston head (108) and the piston rod (106) in a presence of a pressurized fluid provided to retract the piston rod ( 106). The pressurized fluid is introduced into the piston chamber (107) and the piston rod (106) is retracted only after the lock (120) is unlocked.

Abstract: Substituted sulfonamide compounds corresponding to formula I: processes for the preparation thereof, pharmaceutical compositions containing these compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment and/or inhibition of pain and other conditions at least partly mediated by the bradykinin 1 receptor.

Abstract: Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.

Abstract: The invention relates to a liquid-crystalline medium comprising at least one compound of the formula I in which Z1, Z2, Z3, a, b and c are as defined in Claim 1, and to electro-optical displays containing a liquid-crystalline medium of this type.

Abstract: The invention relates to a liquid-crystalline medium comprising at least one compound of the formula I in which X, Z1, Z2, Z3, a, b and c are as defined in Claim 1, and to electro-optical displays containing a liquid-crystalline medium of this type.

Abstract: Liquid-crystalline media comprising at least one compound of the formula I in which X, L1, L2 and L3 are as defined herein, are useful for use in electro-optical displays.

Abstract: The invention relates to a liquid crystalline medium, based on a mixture of polar compounds with a positive dielectric anisotropy. Said medium is characterised in that it contains one or more compounds of formula (I) wherein R, A1, A2, Z1, Z2, X1, X2, n and o are defined as per claim 1.

Abstract: The invention relates to a liquid crystalline medium, based on a mixture of polar compounds with a positive dielectric anisotropy. Said medium is characterised in that it contains one or more compounds of formula (I), wherein R, A1, A2, Z1, Z2, X1, X2, n and o are defined as per claim 1.

Abstract: The invention relates to a liquid-crystalline medium comprising at least one compound of the formula I 1

Abstract: Liquid-crystalline media comprising at least one compound of the formula I 1

Abstract: A new method and apparatus for detecting outliers, more specifically false-negatives and/or false-positives, in pharmaceutical mass screening experiments is provided which utilizes chemical descriptor methodology in conjunction with supervised learning techniques. This method employs the latent structure-activity relationship between the chemical compounds and the biological activity for the detection of such outliers. The method is applicable to individual compounds as well as to pools or mixture of compounds.